LGRNX
Price
$27.89
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
RGAHX
Price
$74.67
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
Ad is loading...

LGRNX vs RGAHX

Header iconLGRNX vs RGAHX Comparison
Open Charts LGRNX vs RGAHXBanner chart's image
Loomis Sayles Growth N
Price$27.89
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$74.67
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LGRNX vs RGAHX Comparison Chart
Loading...
VS
LGRNX vs. RGAHX commentary
Sep 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRNX is a StrongBuy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 284B vs. LGRNX (14.5B). RGAHX pays higher dividends than LGRNX: RGAHX (0.64) vs LGRNX (0.00). LGRNX was incepted earlier than RGAHX: LGRNX (12 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. LGRNX (13.00). RGAHX has a lower initial minimum investment than LGRNX: RGAHX (250) vs LGRNX (1000000). RGAHX (23.85) and LGRNX (23.41) have marching annual gain over last year. LGRNX return over 5 years is better than : 60.20 vs. RGAHX (50.41).
LGRNXRGAHXLGRNX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD19.75119.759100%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets14.5B284B5%
Annual Yield % from dividends0.000.64-
Returns for 1 year23.4123.8598%
Returns for 3 years4.73-2.78-170%
Returns for 5 years60.2050.41119%
Returns for 10 years179.03N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACA91.941.12
+1.23%
Arcosa
PPTA8.89-0.08
-0.84%
Perpetua Resources Corp
TARS31.05-0.83
-2.60%
Tarsus Pharmaceuticals
CSGP75.73-2.17
-2.79%
CoStar Group
ESLA0.90-0.07
-7.49%
Estrella Immunopharma